The PBS Update May 2026: Fruquinitinib for eligible mCRC patients + new haematology options

Send us Fan MailProudly Produced by The Oncology NetworkProfessor Craig Underhill and Rachael Babin break down the key oncology changes from the May 2026 PBS update.This month we run through 3 fresh PBS listings that affect Australian oncology and haematology practice, from fruquintinib, a late-line colorectal cancer treatment, through to new haematology options.  Follow The PBS Update for regular discussions of PBS listings and oncology policy changes affecting Australian healthcare professionals.Visit the Show Notes for links to the updates discussed in this episode and to send us audio feedback or questions for future episodes.